{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:59:00Z","timestamp":1780448340024,"version":"3.54.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T00:00:00Z","timestamp":1624320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T00:00:00Z","timestamp":1624320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005722","name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005722","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>To investigate the sensitivity of the color vision test by Arden in patients with dysthyroid optic neuropathy (DON) to improve diagnosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this observational, retrospective study, we included the medical records of 92 eyes (48 patients) with diagnosis of DON between 2008 and 2019 in order to evaluate the full spectrum of findings from the color vision test by Arden, and to determine potential importance of this test. Thirty-five patients were female, and 13 patients were male. The mean age was 58.0\u00a0years (range: 34\u201379) at the time of the DON diagnosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Forty-one eyes displayed relatively good BCVA with\u2009\u2264\u20090.2 LogMAR. We found a protan value exceeding the threshold of\u2009\u2265\u20098% in 57 eyes (30 patients) at the time of the diagnosis. The sensitivity of protan was 61.9% (95% CI 51.2\u201371.8%), while that of tritan was a striking 98.9% (95% CI 94.1\u201399.9%).<\/jats:p>\n                <jats:p>We discovered one pathological sign, tritan deficiency (based on a threshold of\u2009\u2265\u20098%) consistently in all eyes but one at the time of the diagnosis, regardless of the visual field defects or any changes in best-corrected visual acuity (BCVA).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>We found blue-yellow (tritan) deficiency, to be a sensitive and reliable indicator of dysthyroid optic neuropathy. We conclude that, in cases with suspected DON, a color vision test that can detect tritan deficiency is an essential tool for the adequate assessment, diagnosis, and treatment of DON.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00417-021-05227-8","type":"journal-article","created":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T22:02:15Z","timestamp":1624399335000},"page":"3421-3426","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["A pathological indicator for dysthyroid optic neuropathy: tritan color vision deficiency"],"prefix":"10.1007","volume":"259","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8676-6781","authenticated-orcid":false,"given":"Aylin","family":"Garip Kuebler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Halfter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Reznicek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemarie","family":"Klingenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siegfried","family":"Priglinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnther","family":"Rudolph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Hintschich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,22]]},"reference":[{"issue":"1","key":"5227_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/IIO.0000000000000101","volume":"56","author":"AJ Victores","year":"2016","unstructured":"Victores AJ, Takashima M (2016) Thyroid eye disease: optic neuropathy and orbital decompression. Int Ophthalmol Clin 56(1):69\u201379","journal-title":"Int Ophthalmol Clin"},{"issue":"3","key":"5227_CR2","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/eye.2012.284","volume":"27","author":"DH Verity","year":"2013","unstructured":"Verity DH, Rose GE (2013) Acute thyroid eye disease (TED): principles of medical and surgical management. Eye (Lond) 27(3):308\u2013319","journal-title":"Eye (Lond)"},{"issue":"20","key":"5227_CR3","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1056\/NEJM199311113292007","volume":"329","author":"RS Bahn","year":"1993","unstructured":"Bahn RS, Heufelder AE (1993) Pathogenesis of Graves\u2019 ophthalmopathy. N Engl J Med 329(20):1468\u20131475","journal-title":"N Engl J Med"},{"key":"5227_CR4","first-page":"477","volume":"92","author":"GB Bartley","year":"1994","unstructured":"Bartley GB (1994) The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted County. Minnesota Trans Am Ophthalmol Soc 92:477\u2013588","journal-title":"Minnesota Trans Am Ophthalmol Soc"},{"issue":"11","key":"5227_CR5","first-page":"1515","volume":"95","author":"JM Neigel","year":"1988","unstructured":"Neigel JM, Rootman J, Belkin RI et al (1988) Dysthyroid optic neuropathy. The crowded orbital apex syndrome Ophthalmology 95(11):1515\u20131521","journal-title":"The crowded orbital apex syndrome Ophthalmology"},{"issue":"3","key":"5227_CR6","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1089\/thy.2007.0315","volume":"18","author":"L Bartalena","year":"2008","unstructured":"Bartalena L, Baldeschi L, Dickinson AJ et al (2008) Consensus statement of the European group on Graves\u2019 orbitopathy (EUGOGO) on management of Graves\u2019 orbitopathy. Thyroid 18(3):333\u2013346","journal-title":"Thyroid"},{"issue":"1","key":"5227_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1046\/j.1365-2265.1997.2331047.x","volume":"47","author":"MP Mourits","year":"1997","unstructured":"Mourits MP, Prummel MF, Wiersinga WM et al (1997) Clinical activity score as a guide in the management of patients with Graves\u2019 ophthalmopathy. Clin Endocrinol (Oxf) 47(1):9\u201314","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"5227_CR8","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1055\/s-2008-1034667","volume":"215","author":"T Berninger","year":"1999","unstructured":"Berninger T, Drobner B, Hogg C et al (1999) Color vision in relation to age: a study of normal values. Klin Monbl Augenheilkd 215(1):37\u201342","journal-title":"Klin Monbl Augenheilkd"},{"issue":"2","key":"5227_CR9","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/BF00153698","volume":"69","author":"G Arden","year":"1988","unstructured":"Arden G, Gunduz K, Perry S (1988) Color vision testing with a computer graphics system: preliminary results. Doc Ophthalmol 69(2):167\u2013174","journal-title":"Doc Ophthalmol"},{"issue":"7","key":"5227_CR10","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1001\/archopht.1988.01060140075028","volume":"106","author":"K Gunduz","year":"1988","unstructured":"Gunduz K, Arden GB, Perry S et al (1988) Color vision defects in ocular hypertension and glaucoma Quantification with a computer-driven color television system. Arch Ophthalmol 106(7):929\u201335","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"5227_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1093\/bmb\/ldx007","volume":"122","author":"JL Barbur","year":"2017","unstructured":"Barbur JL, Rodriguez-Carmona M (2017) Colour vision requirements in visually demanding occupations. Br Med Bull 122(1):51\u201377","journal-title":"Br Med Bull"},{"key":"5227_CR12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1136\/bjophthalmol-2020-316433","volume":"1","author":"A Garip-Kuebler","year":"2020","unstructured":"Garip-Kuebler A, Halfter K, Reznicek L et al (2020) Subclinical dysthyroid optic neuropathy: tritan deficiency as an early sign of dysthyroid optic neuropathy. Br J Ophthalmol 1:5. https:\/\/doi.org\/10.1136\/bjophthalmol-2020-316433","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"5227_CR13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s10633-012-9325-2","volume":"125","author":"C Perez-Rico","year":"2012","unstructured":"Perez-Rico C, Rodriguez-Gonzalez N, Arevalo-Serrano J et al (2012) Evaluation of multifocal visual evoked potentials in patients with Graves\u2019 orbitopathy and subclinical optic nerve involvement. Doc Ophthalmol 125(1):11\u201319","journal-title":"Doc Ophthalmol"},{"key":"5227_CR14","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.ajo.2019.12.005","volume":"213","author":"SK Freitag","year":"2020","unstructured":"Freitag SK, Tanking T (2020) A nomenclature to describe the sequence of visual field defects in progressive thyroid eye disease-compressive optic neuropathy (an American Ophthalmological Society Thesis). Am J Ophthalmol 213:293\u2013305","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"5227_CR15","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1136\/bjo.2006.094607","volume":"91","author":"D McKeag","year":"2007","unstructured":"McKeag D, Lane C, Lazarus JH, Baldeschi L et al (2007) Clinical features of dysthyroid optic neuropathy: a European Group on Graves\u2019 Orbitopathy (EUGOGO) survey. Br J Ophthalmol 91(4):455\u2013458","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"5227_CR16","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.survophthal.2015.11.004","volume":"61","author":"MP Simunovic","year":"2016","unstructured":"Simunovic MP (2016) Acquired color vision deficiency. Surv Ophthalmol 61(2):132\u2013155","journal-title":"Surv Ophthalmol"},{"issue":"2","key":"5227_CR17","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s00417-012-2073-x","volume":"251","author":"R Huna-Baron","year":"2013","unstructured":"Huna-Baron R, Glovinsky Y, Habot-Wilner Z (2013) Comparison between Hardy-Rand-Rittler 4th edition and Ishihara color plate tests for detection of dyschromatopsia in optic neuropathy. Graefes Arch Clin Exp Ophthalmol 251(2):585\u20139","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6","key":"5227_CR18","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.ajo.2010.01.011","volume":"149","author":"Y Almog","year":"2010","unstructured":"Almog Y, Nemet A (2010) The correlation between visual acuity and color vision as an indicator of the cause of visual loss. Am J Ophthalmol 149(6):1000\u20131004","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"5227_CR19","first-page":"457","volume":"10","author":"AE Krill","year":"1971","unstructured":"Krill AE, Smith VC, Pokorny J (1971) Further studies supporting the identity of congenital tritanopia and hereditary dominant optic atrophy. Invest Ophthalmol 10(6):457\u2013465","journal-title":"Invest Ophthalmol"},{"issue":"5","key":"5227_CR20","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1007\/s10792-014-9911-2","volume":"34","author":"E Jafarzadehpur","year":"2014","unstructured":"Jafarzadehpur E, Hashemi H, Emamian MH et al (2014) Color vision deficiency in a middle-aged population: the Shahroud Eye Study. Int Ophthalmol 34(5):1067\u20131074","journal-title":"Int Ophthalmol"},{"issue":"11","key":"5227_CR21","first-page":"2278","volume":"38","author":"ME Schneck","year":"1997","unstructured":"Schneck ME, Haegerstrom-Portnoy G (1997) Color vision defect type and spatial vision in the optic neuritis treatment trial. Invest Ophthalmol Vis Sci 38(11):2278\u20132289","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5227_CR22","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1364\/JOSA.53.000185","volume":"53","author":"G Verriest","year":"1963","unstructured":"Verriest G (1963) Further studies on acquired deficiency of color discrimination. J Opt Soc Am 53:185\u2013195","journal-title":"J Opt Soc Am"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-021-05227-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-021-05227-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-021-05227-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T06:28:08Z","timestamp":1634538488000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-021-05227-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,22]]},"references-count":22,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["5227"],"URL":"https:\/\/doi.org\/10.1007\/s00417-021-05227-8","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,22]]},"assertion":[{"value":"10 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and\nwith the Helsinki declaration and its later amendments or comparable ethical standards.\nWe obtained approval from the Ethics Committee of the Ludwig-Maximilians-University, Munich, Germany.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}